Maria Sklodowska-Curie National Research Institute of Oncology

The use of targeted molecular therapies in combination with surgical treatment and radical radiotherapy

Discipline
Medical Oncology
Programme mentors
Dr. hab. med. Adam Płużański
Duration
3 months
Type
Visiting Observership
Language requirements
English

Programme description

This program focuses on the integration of targeted molecular therapies with surgical treatment and radical radiotherapy in the management of various cancers. It aims to provide healthcare professionals with in-depth knowledge and practical insights into combining these advanced treatment modalities to optimize patient outcomes.

Key focus areas include:

  • Understanding the mechanisms of action of targeted molecular therapies
  • Evidence supporting the combination of targeted therapies with surgery and radical radiotherapy
  • Patient selection criteria and treatment sequencing
  • Potential benefits and challenges of combining therapies
  • Monitoring patient response and managing side effects
  • Case studies and real-world applications

The program is designed for oncology professionals interested in advancing their knowledge and clinical practice in multidisciplinary cancer treatment, with an emphasis on innovation, evidence-based care, and translational research.

Programme offered by:
Maria Sklodowska-Curie National Research Institute of Oncology

Person responsible for CTC programme:

Dr hab. n med. Iwona Ługowska